Internal Medicine · Cleveland, MS
NPI
1053408476
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
810 E Sunflower Rd
Cleveland, MS, 38732
Phone (662) 843-3606
Groups this clinician bills Medicare through
Medicare paid, 2024
$790K
42,505 services
Medicare patients, 2024
1,695
Average age 74
Drug cost, 2024
$4.8M
47,794 prescriptions
Company payments, 2025
$857
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven G Clark was code J1010 (injection, methylprednisolone acetate, 1 mg), 7,920 times for 70 patients. In total Steven G Clark billed 42,505 services in 178 codes, and Medicare paid $790K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 7,920 | 70 | $0.10 | $772 |
| J0897 Injection, denosumab, 1 mg | Office | 4,865 | 60 | $20.27 | $99K |
| 93010 Electrocardiogram | Facility | 3,137 | 928 | $5.92 | $19K |
| 99214 Office E&M - Established | Office | 1,914 | 774 | $75.25 | $144K |
| 85025 Blood Count | Office | 1,836 | 842 | $7.53 | $14K |
| 81003 Clinical Chemistry | Office | 1,308 | 721 | $2.16 | $2,827 |
| 80053 Clinical Chemistry | Office | 1,270 | 739 | $10.25 | $13K |
| 96372 Injection Administration | Office | 878 | 364 | $8.11 | $7,124 |
| 84443 Clinical Chemistry | Office | 870 | 648 | $16.42 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 866 | 507 | $10.93 | $9,465 |
| 83036 Blood Count | Office | 836 | 544 | $9.25 | $7,733 |
| 80048 Clinical Chemistry | Office | 732 | 392 | $8.14 | $5,961 |
| 99213 Office E&M - Established | Office | 697 | 430 | $54.83 | $38K |
| 80061 Clinical Chemistry | Office | 662 | 580 | $12.78 | $8,462 |
| 99232 Hospital E&M - Subsequent | Facility | 554 | 225 | $57.31 | $32K |
By year: 2022 $840K for 38,837 services; 2023 $779K for 33,613 services; 2024 $790K for 42,505 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,836 | 842 | $7.53 | $14K |
| 81003 Clinical Chemistry | 1,308 | 721 | $2.16 | $2,827 |
| 80053 Clinical Chemistry | 1,270 | 739 | $10.25 | $13K |
| 84443 Clinical Chemistry | 870 | 648 | $16.42 | $14K |
| 83036 Blood Count | 836 | 544 | $9.25 | $7,733 |
| 80048 Clinical Chemistry | 732 | 392 | $8.14 | $5,961 |
| 80061 Clinical Chemistry | 662 | 580 | $12.78 | $8,462 |
| 82607 Clinical Chemistry | 452 | 400 | $14.49 | $6,548 |
| 83880 Clinical Chemistry | 401 | 201 | $37.86 | $15K |
| 84481 Clinical Chemistry | 349 | 228 | $16.24 | $5,667 |
Medicare prescription drug claims, 2024
In 2024, the drug Steven G Clark prescribed most often to Medicare patients was Amlodipine Besylate, with 1,932 prescriptions and refills. In total Steven G Clark wrote 47,794 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,932 | 3,725 | 465 | $13K |
| Potassium Chloride Generic | 1,699 | 2,648 | 353 | $38K |
| Pantoprazole Sodium Generic | 1,461 | 2,436 | 307 | $17K |
| Levothyroxine Sodium Generic | 1,378 | 2,474 | 263 | $12K |
| Furosemide Generic | 1,375 | 2,121 | 300 | $9,280 |
| Atorvastatin Calcium Generic | 1,370 | 2,664 | 309 | $12K |
| Famotidine Generic | 1,319 | 2,075 | 259 | $13K |
| Metoprolol Succinate Generic | 1,131 | 2,211 | 288 | $13K |
| Olmesartan Medoxomil Generic | 1,037 | 2,167 | 273 | $14K |
| Rosuvastatin Calcium Generic | 984 | 2,167 | 263 | $11K |
| Gabapentin Generic | 913 | 1,305 | 173 | $10K |
| Eliquis Apixaban | 909 | 1,243 | 160 | $640K |
| Losartan Potassium Generic | 744 | 1,436 | 170 | $7,687 |
| Clopidogrel Clopidogrel Bisulfate | 653 | 1,247 | 151 | $6,260 |
| Jardiance Empagliflozin | 648 | 989 | 121 | $538K |
Brand drugs: 7,372 claims; generic drugs: 40,215 claims; opioid claims: 1,082.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven G Clark $857 ($857 in general payments such as food, travel and fees) from 14 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $204.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 5 | $204 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $158 |
| Lilly USA, LLC LLY | 4 | $84.38 |
| Alpha Cognition USA, Inc. ACOG | 1 | $67.69 |
| Novo Nordisk Inc NVO | 3 | $52.03 |
| Eisai Inc. 4523.T | 2 | $44.59 |
| Astellas Pharma US Inc 4503.T | 2 | $40.18 |
| Dexcom, Inc. DXCM | 2 | $38.37 |
| Abbvie Inc. ABBV | 2 | $36.93 |
| Pfizer Inc. PFE | 2 | $34.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.